Trials / Completed
CompletedNCT04123938
Pea Protein and Muscle Mass During Weight Loss
A Pilot Study to Examine the Effect of Pea Protein on Limiting the Loss of Muscle Mass During Weight Loss
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- University of Manitoba · Academic / Other
- Sex
- All
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
A pilot study comparing the effects of pea protein versus whey protein on the preservation of muscle mass and functionality in individuals undertaking a weight loss regimen.
Detailed description
A single site, double-blind, randomized clinical trial designed to compare the effects of pea protein or whey protein or maltodextrin supplementation on muscle mass and functionality in males and females with obesity undertaking a weight loss regimen. Eligible participants will be randomized to one of the three groups (pea protein, whey protein, maltodextrin) and will be asked to attend 3 in-person clinic visits (0, 6, and 12 weeks) for blood and urine collection and assessments of muscle mass and muscle function. A separate visit for screening and for a fasting blood sample, as well as a Pre-Study visit and a meeting with a registered dietitian, will be required.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pea Protein | Soluble pea protein |
| OTHER | Whey Protein | Whey protein concentrate |
| OTHER | Maltodextrin | Non-protein isocaloric comparator |
Timeline
- Start date
- 2019-10-17
- Primary completion
- 2023-05-02
- Completion
- 2023-05-02
- First posted
- 2019-10-11
- Last updated
- 2025-09-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04123938. Inclusion in this directory is not an endorsement.